HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease.

Abstract
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis of an unknown origin. The prognosis of ECD is variable, and it mainly depends on the involved anatomic sites. The treatment modalities have not been standardized. Interferon-alpha (IFN) has been reported to be effective in the management of ECD. We report here on an uncommon case with ECD in a 17-year-old female who had multiple lesions in the whole body and she was treated with chemotherapy and IFN. She has remained disease-free for 2 years after the completion of treatment.
AuthorsIn-sang Jeon, Sang Seon Lee, Min Kyung Lee
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 55 Issue 4 Pg. 745-7 (Oct 2010) ISSN: 1545-5017 [Electronic] United States
PMID20589628 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2010 Wiley-Liss, Inc.
Chemical References
  • Interferon-alpha
  • Vinblastine
  • Prednisone
  • Methotrexate
Topics
  • Adolescent
  • Erdheim-Chester Disease (diagnosis, drug therapy)
  • Female
  • Humans
  • Interferon-alpha (therapeutic use)
  • Methotrexate (administration & dosage)
  • Prednisone (administration & dosage)
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: